Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis BioNTech SE BNTX

Healthcare Biotechnology
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a... see more

Opinion & Analysis (NDAQ:BNTX)

    BioNTech & Cardiol Therapeutics – on the verge of a breakout

    Stefan Feulner May 22, 2024

    Takeover rumours: BioNTech, Cardiol Therapeutics and Novo Nordisk in focus

    André Will-Laudien April 24, 2024

    CureVac, BioNTech, Valeo Pharma: Where is there still potential?

    Nico Popp October 16, 2020

    BioNTech, Bayer, Valeo Pharma: Share price jump ahead of quarterly results

    Mario Hose September 29, 2020

    BioNTech, CureVac, or Valeo Pharma: who brings the highest return to shareholders?

    Mario Hose September 23, 2020

    BioNTech, CureVac, EXMceuticals - reaching their goal with government support

    Mario Hose September 18, 2020

    BioNTech, CureVac, Valeo Pharma - COVID-19 wakes up the industry

    Mario Hose September 1, 2020

    BioNTech, Eastman Kodak, EXMceuticals - investors have the chance to profit

    Mario Hose July 29, 2020

    BioNTech, Saturn Oil & Gas, TUI - Investments with potential

    Mario Hose July 15, 2020

    BioNTech, EXMceuticals, XPhyto - Covid-19 and legalizations offer potential

    Mario Hose July 15, 2020

    BioNTech, Evotec, EXMceuticals - which stocks have the potential to double?

    Mario Hose June 18, 2020

    BioNTech, Evotec, XPhyto - will the next rally start?

    Mario Hose May 26, 2020

    BioNTech, EXMceuticals, Shop Apotheke Europe, Symrise - Shares gaining momentum

    Mario Hose May 14, 2020

    BioNTech, Gilead, Memphasys - in the spotlight of investors overnight

    Mario Hose April 24, 2020

    BioNTech, Evotec, EXMceuticals - Stocks with potential

    Mario Hose April 15, 2020

    BioNTech, Gilead, Memphasys - modern science and COVID and IVF

    Mario Hose March 19, 2020